Studies of Heritable Disorders of Connective Tissue
Learn more about:
Related Clinical Trial
Measurement of Heart-carotid Pulse Wave Velocity (hcPWV) by Laser Doppler Vibrometry (LDV)
Analysis of Muscular Properties in Patients With MFS and EDS
Psychological Support in Adult Patients With Marfan Syndrome
Marfan Syndrome (MFS) and Facial Dysmorphism: Non-invasive 3D Assessment
Transcriptomic Study of Adult Population With Marfan Syndrome
Surgical Treatment of Marfan Syndrome With Subluxation Lens
Safety and Performance of POLYTHESE® Vascular Prosthesis
Proximal Aortopathy in Scotland – Epidemiology and Surgical Outcomes
Biological Collection for Marfan and Related Syndromes
Mortality and Morbidity Outcomes in Marfans
Living With Marfans and Your Aorta: Surgical Outcomes Study
Living With Marfan Syndrome and Your Aorta
Effect on the Quality of Life of a Therapeutic Education Program in Patients With Marfan Syndrome
Marfan Syndrome Moderate Exercise Pilot
Effects of Personalized Training at Home Combining Endurance and Resistance in Patients Suffering From Marfan Syndrome
Study of Heritable Connective Tissue Disorders
Complex Aortic Aneurysm Repair Using Physician Modified Endografts and Custom Made Devices
Comparison of Aliskiren vs Negative Controls on Aortic Stiffness in Patients With MFS
Tele-Clinic Visits in Pediatric Marfan Patients Using Parental Echo: The Future?
Thoracic Aortic Dilatation Syndromes
Studies of Heritable Disorders of Connective Tissue
The Oxford Marfan Trial
Losartan Versus Atenolol for the Treatment of Marfan Syndrome
A Randomized, Open-label, LOSARTAN Therapy on the Progression of Aortic Root Dilation in Patients With Marfan Syndrome
Randomized, Double-blind Study for the Evaluation of the Effect of Losartan Versus Placebo on Aortic Root Dilatation in Patients With Marfan Syndrome Under Treatment With Beta-blockers
Children and Adolescents With Marfan Syndrome: 10,000 Healthy Steps and Beyond
Circulating Transforming Growth Factor Beta (TGF-β) in Individuals With Marfan Syndrome
Nebivolol Versus Losartan Versus Nebivolol+Losartan Against Aortic Root Dilation in Genotyped Marfan Patients
Generation of Marfan Syndrome and Fontan Cardiovascular Models Using Patient-specific Induced Pluripotent Stem Cells
Comparison of Two Medications Aimed at Slowing Aortic Root Enlargement in Individuals With Marfan Syndrome–Pediatric Heart Network
Study of the Efficacy of Losartan on Aortic Dilatation in Patients With Marfan Syndrome
Effects of Losartan Versus Atenolol on Aortic and Cardiac Muscle Stiffness in Adults With Marfan Syndrome
Development of a Blood Test for Marfan Syndrome
Cardiorespiratory and Muscular Rehabilitation of Children and Young Adults With Marfan Syndrome.
Comparison of Medical Therapies in Marfan Syndrome.
Classifying Ectopia Lentis in Marfan Syndrome Into Five Grades of Increasing Severity
Clinical Variability in Marfan Syndrome
Angiotensin Converting Enzyme Inhibitors in Marfan Syndrome
Atenolol Versus Losartan in the Prevention of Progressive Dilation of the Aorta in Marfan Syndrome